openPR Logo
Press release

Bronchiolitis Obliterans Syndrome Market is set for Steady Growth, with a robust CAGR anticipated by 2034, estimates DelveInsight | ambon Pharma, GlaxoSmithKline, Incyte Corporation, Mereo Biopharma, Genentech

02-06-2025 01:37 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Bronchiolitis Obliterans Syndrome Drugs Market

Bronchiolitis Obliterans Syndrome Drugs Market

DelveInsight's "Bronchiolitis Obliterans Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding, historical and forecasted epidemiology, as well as the Bronchiolitis Obliterans Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

Discover Key Insights into the Bronchiolitis Obliterans Syndrome Market with DelveInsight's In-Depth Report @ Bronchiolitis Obliterans Syndrome Market Size- https://www.delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Bronchiolitis Obliterans Syndrome Market Report
• According to DelveInsight, in 2022, the total diagnosed prevalent cases of Bronchiolitis Obliterans Syndrome (BOS) were approximately 17,000 in the United States, which is expected to grow during the study period, i.e., 2019-2032.
• The highest number of total diagnosed prevalent cases of Bronchiolitis Obliterans Syndrome (BOS) was observed in Germany among EU4 and the UK, with approximately 3,900 cases in 2022 which are expected to grow during the study period, i.e., 2019-2032.
• In 2022, the total diagnosed prevalent cases of Bronchiolitis Obliterans Syndrome (BOS) were approximately 2,400 cases in Japan, which is expected to grow during the study period, i.e., 2019-2032.
• The leading Bronchiolitis Obliterans Syndrome Companies such as Zambon Pharma, GlaxoSmithKline, Incyte Corporation, Mereo Biopharma, Genentech, and others.
• Promising Bronchiolitis Obliterans Syndrome Therapies such as ARINA-1, Belumosudil, Fluticasone, Azithromycin, LAM-001, Ruxolitinib, and others.

Stay ahead in the Bronchiolitis Obliterans Syndrome Therapeutics Market with DelveInsight's Strategic Report @ Bronchiolitis Obliterans Syndrome Market Outlook- https://www.delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bronchiolitis Obliterans Syndrome Epidemiology Segmentation in the 7MM
• Total Bronchiolitis Obliterans Syndrome Diagnosed Prevalent Cases
• Bronchiolitis Obliterans Syndrome Grade-specific Cases
• Total Bronchiolitis Obliterans Syndrome Treated Cases

Download the report to understand which factors are driving Bronchiolitis Obliterans Syndrome epidemiology trends @ Bronchiolitis Obliterans Syndrome Prevalence- https://www.delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bronchiolitis Obliterans Syndrome Emerging Drugs Profile
• Liposomal Cyclosporine A: Zambon Pharma
Liposomal Cyclosporine A for inhalation (L-CsA-i) is a novel liposomal formulation of cyclosporine A developed for inhaled delivery to the lungs. Calcineurin inhibitors (CNIs), like cyclosporine A, are highly potent immunosuppressive drugs and a cornerstone of lung transplant medicine. L-CsA-i is administered via a drug-specific investigational eFlow technology nebulizer system. The investigational drug-device combination is designed to deliver L-CsA-i to the site of disease in the lung. L-CsA-i is currently being evaluated to treat Bronchiolitis Obliterans Syndrome (BOS) in patients aged 6 years and older in the BOSTON clinical development program, which comprises five ongoing or planned trials.

• MPH966 (alvelestat): Mereo Biopharma
MPH-966 (formerly AZD 9668) is a novel, oral-small molecule that inhibits neutrophil elastase (NE). This neutrophil protease is a key enzyme in destroying lung tissues. Alvelestat is currently being investigated in Phase I/II study in adult patients who have undergone hematopoietic stem cell transplantation and were diagnosed with Bronchiolitis Obliterans Syndrome (BOS). Interim results of Phase I/II clinical study of alvelestat have shown efficacious in the treatment of Bronchiolitis Obliterans Syndrome (BOS). Alvelestat is a disease-modifying agent and can be a blockbuster in treating Bronchiolitis Obliterans Syndrome (BOS).

Bronchiolitis Obliterans Syndrome Market Outlook
Treatment of Bronchiolitis Obliterans Syndrome (BOS) after lung transplant/allo-HSCT involves augmenting immunosuppression as a form of chronic rejection. Hence, increasing or adding immunosuppressive agents like tacrolimus, cyclosporine, mycophenolate mofetil, and prednisone are used to treat Bronchiolitis Obliterans Syndrome (BOS) after transplant. Azithromycin has been demonstrated to improve lung function and lower the incidence of Bronchiolitis Obliterans Syndrome (BOS). The reduction in lung function in Bronchiolitis Obliterans Syndrome (BOS) post-HSCT can be slowed down by combining inhaled fluticasone, oral montelukast, and Zithromax.

Get In-Depth Knowledge on Bronchiolitis Obliterans Syndrome Market Trends and Forecasts with DelveInsight @ Bronchiolitis Obliterans Syndrome Treatment Market- https://www.delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Bronchiolitis Obliterans Syndrome Market Report
• Coverage- 7MM
• Bronchiolitis Obliterans Syndrome Companies- Zambon Pharma, GlaxoSmithKline, Incyte Corporation, Mereo Biopharma, Genentech, and others.
• Bronchiolitis Obliterans Syndrome Therapies- ARINA-1, Belumosudil, Fluticasone, Azithromycin, LAM-001, Ruxolitinib, and others.
• Bronchiolitis Obliterans Syndrome Market Dynamics: Bronchiolitis Obliterans Syndrome Market Drivers and Barriers
• Bronchiolitis Obliterans Syndrome Market Access and Reimbursement, Unmet Needs and Future Perspectives

Unlock Strategic Insights with DelveInsight's Comprehensive Bronchiolitis Obliterans Syndrome Market Report @ Bronchiolitis Obliterans Syndrome Market Drivers and Barriers- https://www.delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Report Introduction
3. Bronchiolitis Obliterans Syndrome (BOS) Market Overview at a Glance
4. Executive Summary of Bronchiolitis Obliterans Syndrome (BOS)
5. Bronchiolitis Obliterans Syndrome Epidemiology and Market Methodology
6. Disease Background and Overview
7. Bronchiolitis Obliterans Syndrome Epidemiology and Patient Population
8. Bronchiolitis Obliterans Syndrome Patient Journey
9. Key Endpoints in Bronchiolitis Obliterans Syndrome (BOS) Clinical Trials
10. Emerging Bronchiolitis Obliterans Syndrome Therapies
11. Bronchiolitis Obliterans Syndrome: 7 Major Market Analysis
12. Bronchiolitis Obliterans Syndrome Market Access and Reimbursement
13. Bronchiolitis Obliterans Syndrome KOL Views
14. SWOT Analysis
15. Bronchiolitis Obliterans Syndrome Unmet Needs
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight

List of Top Selling Market Research Reports in 2025

Surgical Lasers Market - https://www.delveinsight.com/report-store/surgical-lasers-market
Intraocular Lens Market - https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Myeloproliferative Neoplasms Market - https://www.delveinsight.com/report-store/myeloproliferative-neoplasms-market
Skin Neoplasm Market - https://www.delveinsight.com/report-store/nonmelanoma-skin-cancer-market
Healthcare Competitive Benchmarking - https://www.delveinsight.com/consulting/competitive-benchmarking-services
Microscopy Device Market - https://www.delveinsight.com/report-store/microscopy-device-market
Pacemakers Market - https://www.delveinsight.com/report-store/pacemakers-market
Urea Cycle Disorders Market - https://www.delveinsight.com/blog/urea-cycle-disorder-market
Novel Drug Delivery Devices Market - https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Nk Cell Therapy Market - https://www.delveinsight.com/infographics/nk-cell-therapy-market
Surgical Mask & Respirator Market - https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Lymphoedema Market - https://www.delveinsight.com/report-store/lymphoedema-market
Phototherapies For Psoriasis Market - https://www.delveinsight.com/report-store/phototherapy-devices-market
Sepsis Market - https://www.delveinsight.com/report-store/sepsis-market
Bone Growth Stimulator Market - https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Antibody Drug Conjugate Market - https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
Overactive Bladder Syndrome Market - https://www.delveinsight.com/report-store/underactive-bladder-market
Medical Marijuana Market - https://www.delveinsight.com/report-store/medical-marijuana-market
Lactose Intolerance Market - https://www.delveinsight.com/report-store/lactose-intolerance-market
Catheter Stabilization Devices Market - https://www.delveinsight.com/sample-request/catheter-stabilization-securement-device-market
Total Knee Arthroplasty Market - https://www.delveinsight.com/report-store/knee-reconstruction-devices-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchiolitis Obliterans Syndrome Market is set for Steady Growth, with a robust CAGR anticipated by 2034, estimates DelveInsight | ambon Pharma, GlaxoSmithKline, Incyte Corporation, Mereo Biopharma, Genentech here

News-ID: 3854282 • Views:

More Releases from DelveInsight Business Research LLP

Erectile Dysfunction Devices Market Outlook Report 2032 by DelveInsight Exploring Market Drivers, Key Growth Challenges, Technological Advancements, and Future Market Potential
Erectile Dysfunction Devices Market Outlook Report 2032 by DelveInsight Explorin …
DelveInsight's Erectile Dysfunction Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Erectile Dysfunction Devices Companies market shares, challenges, Erectile Dysfunction Devices Market Drivers, barriers, trends, and key market Erectile Dysfunction Devices companies in the market. To read more about the latest highlights related to the Erectile Dysfunction Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/erectile-dysfunction-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key
Structural Heart Devices Market Size Report 2032: DelveInsight Report on Demand Surge, Clinical Effectiveness, Technological Progress, and Global Market Growth Trajectory
Structural Heart Devices Market Size Report 2032: DelveInsight Report on Demand …
DelveInsight's Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Structural Heart Devices Market Drivers, barriers, trends, and key market Structural Heart Devices companies in the market. To read more about the latest highlights related to the Structural Heart Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways
DelveInsight's Urolithiasis Management Devices Market 2032 Report Offering In-Depth Insights into Market Segmentation, Regional Landscape, Pipeline Products, and Growth Outlook
DelveInsight's Urolithiasis Management Devices Market 2032 Report Offering In-De …
DelveInsight's Urolithiasis Management Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Urolithiasis Management Devices Companies market shares, challenges, Urolithiasis Management Devices Market Drivers, barriers, trends, and key market Urolithiasis Management Devices companies in the market. To read more about the latest highlights related to the Urolithiasis Management Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/urolithiasis-management-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways
Transradial Access Products Market Forecast Report 2032 by DelveInsight Featuring Market Trends, Strategic Collaborations, Innovation Landscape, and Long-Term Growth Prospects
Transradial Access Products Market Forecast Report 2032 by DelveInsight Featurin …
DelveInsight's Transradial Access Products Market Insights Report 2032 provides the current and forecast market analysis, individual leading Transradial Access Products Companies market shares, challenges, Transradial Access Products Market Drivers, barriers, trends, and key market Transradial Access Products companies in the market. To read more about the latest highlights related to the Transradial Access Products Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/transradial-access-products-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways

All 5 Releases


More Releases for Syndrome

"Understanding Rett Syndrome: Trends and Advances in the Rett Syndrome Market"
The Rett Syndrome Market, valued at USD 225.02 million in 2022, is anticipated to surge to USD 515.06 million by 2029, reflecting a significant Compound Annual Growth Rate (CAGR) of 10.23% from 2023 to 2029. Overview of the Rett Syndrome Market: Rett syndrome, a rare genetic neurological and developmental disorder primarily impacting females, hinders brain development and causes progressive loss of motor skills and language. The market report underscores technological advancements
MISME Syndrome Market - Navigating Challenges, Embracing Abilities: MISME Syndro …
Newark, New Castle, USA: The "MISME Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. MISME Syndrome Market: https://www.growthplusreports.com/report/misme-syndrome-market/8883 This latest report researches the industry structure, sales, revenue,
Felty Syndrome Market - A Dedicated Approach to Felty Syndrome Care and Empowerm …
Newark, New Castle, USA: The "Felty Syndrome Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Felty Syndrome Market: https://www.growthplusreports.com/report/felty-syndrome-market/8440 This latest report researches the industry structure, sales, revenue,
MISME Syndrome Market - Transforming Lives: Empowering Recovery from MISME Syndr …
Newark, New Castle, USA - new report, titled MISME Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the MISME Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global MISME Syndrome market. The report offers an overview of the market, which
Hepatorenal Syndrome Market - Reimagining Wellness, Redefining Survival: Hepator …
Newark, New Castle, USA - new report, titled Hepatorenal Syndrome Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Hepatorenal Syndrome market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Hepatorenal Syndrome market. The report offers an overview of the market, which
Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syn …
Global Markets Directs, Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2016, provides an overview of the Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and